CAS 2660250-10-0
:BLU945
Description:
As of my last update in October 2023, BLU945, with the CAS number 2660250-10-0, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth and division. The compound is designed to target specific pathways involved in diseases such as cancer, making it a subject of interest in drug development. BLU945's structure typically includes functional groups that enhance its binding affinity and selectivity for its target kinases. Additionally, its pharmacokinetic properties, such as solubility, stability, and bioavailability, are critical for its efficacy as a therapeutic agent. Ongoing research aims to elucidate its mechanism of action, optimize its chemical properties, and evaluate its safety and effectiveness in clinical settings. As with any investigational compound, further studies are necessary to fully understand its potential benefits and risks.
Formula:C28H37FN6O3S
Synonyms:- BLU-945
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
BLU-945
CAS:<p>BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs).Cost-effective and quality-assured.</p>Formula:C28H37FN6O3SPurity:99.11% - 99.16%Color and Shape:SolidMolecular weight:556.7Ref: IN-DA020M58
1g579.00€5gTo inquire1mg57.00€5mg109.00€10mg124.00€25mg153.00€50mg183.00€100mg176.00€250mg219.00€500mg326.00€BLU-945-13C-d5
CAS:Formula:C2713CH32D5FN6O3SColor and Shape:White Semi-Solid To Solid (Low M P )Molecular weight:562.72
